Neuromuscular junction dysfunction in Miller Fisher syndrome

Seminars in Ophthalmology

Volumn 23, Issue 3, 2008, Pages 211-213

  Silverstein, M P ^a   Zimnowodzki, S ^a   Rucker, J C ^a  

^a RUSH UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Decrement; Miller Fisher; Neuromuscular junction

Indexed keywords

CHOLINERGIC RECEPTOR ANTIBODY; EDROPHONIUM;

ADULT; AREFLEXIA; ARTICLE; CASE REPORT; CEREBROSPINAL FLUID ANALYSIS; COMPUTER ASSISTED TOMOGRAPHY; DIPLOPIA; ELECTROPHYSIOLOGY; EXERCISE; EYE EXAMINATION; EYE MOVEMENT; GUILLAIN BARRE SYNDROME; HUMAN; IMMUNOASSAY; LUMBAR PUNCTURE; MALE; MYASTHENIA GRAVIS; NERVE CONDUCTION; NERVE STIMULATION; NEUROMUSCULAR JUNCTION DISORDER; NEUROMUSCULAR TRANSMISSION; NUCLEAR MAGNETIC RESONANCE IMAGING; OSCILLOPSIA; PARESTHESIA; PRIORITY JOURNAL; PTOSIS; PUPIL REFLEX; VERTIGO;

ADULT; AUTOANTIBODIES; DIPLOPIA; ELECTROPHYSIOLOGY; GANGLIOSIDES; HUMANS; MALE; MILLER FISHER SYNDROME; MYASTHENIA GRAVIS; NEUROMUSCULAR JUNCTION DISEASES;

EID: 42449089876     PISSN: 08820538     EISSN: 17445205     Source Type: Journal    
DOI: 10.1080/08820530802049996     Document Type: Article

References (12)

1. Fisher M. An unusual variant of acute idiopathic polyneuritis (syndrome of ophthalmoplegia, ataxia, and areflexia). N Engl J Med. 1956;255:57-65.
2. O'Hanlon GM, Bullens RW, Plomp JJ, Willison HJ. Complex gangliosides as autoantibody targets at the neuromuscular junction in Miller Fisher syndrome: a current perspective. Neurochem Res. 2002;27:697-709.
3. Yuki N. Acute paresis of extraocular muscles associated with IgG anti-GQ1b antibody. Ann Neurol. 1996;39:668-672.
4. Chan YC, Wilder-Smith E, Chee MW. Acute ophthalmoplegia with pupillary areflexia associated with anti-GQ1b antibody. J Clin Neurosci. 2004;11:658-660.
5. Dorr J, Dieste FJ, Klaasen van Husen D, Zipp F, Vogel HP. A case of recurrent Miller Fisher syndrome mimicking botulism. Neurol Sci. 2006;27:424-425.
6. Cardenas D, Mishra SK, Ohanian AG, Ovbiagele B. Successive yet distinct episodes of isolated ophthalmoplegia associated with anti-GQ1b antibody. Neurology. 2005;65:163.
7. Nishimoto Y, Odaka M, Hirata K, Yuki N. Usefulness of anti-GQ1b IgG antibody testing in Fisher syndrome compared with cerebrospinal fluid examination. J Neuroimmunol. 2004;148:200-205.
8. Odaka M, Yuki N, Hirata K. Anti-GQ1b IgG antibody syndrome: clinical and immunological range. J Neurol Neurosurg Psychiatry. 2001;70:50-55.
9. Bullens RW, O'Hanlon GM, Wagner E, et al. Complex gangliosides at the neuromuscular junction are membrane receptors for autoantibodies and botulinum neurotoxin but redundant for normal synaptic function. J Neurosci. 2002;22:6876-6884.
10. Buchwald B, Bufler J, Carpo M, et al. Combined pre- and postsynaptic action of IgG antibodies in Miller Fisher syndrome. Neurology. 2001;56:67-74.
11. Lo YL, Leoh TH, Dan YF, et al. Presynaptic neuromuscular transmission defect in the Miller Fisher syndrome. Neurology. 2006;66:148-149.
12. Lo YL, Chan LL, Pan A, Ratnagopal P. Acute ophthalmoparesis in the anti-GQ1b antibody syndrome: electrophysiological evidence of neuromuscular transmission defect in the orbicularis oculi. J Neurol Neurosurg Psychiatry. 2004;75:436-440.